<!DOCTYPE html>
<!-- paulirish.com/2008/conditional-stylesheets-vs-css-hacks-answer-neither/
-->
<!--[if lt IE 7]>
<html class="no-js lt-ie9 lt-ie8 lt-ie7" lang="en">
<![endif]-->
<!--[if IE 7]>
<html class="no-js lt-ie9 lt-ie8" lang="en">
<![endif]-->
<!--[if IE 8]>
<html class="no-js lt-ie9" lang="en">
<![endif]-->
<!--[if gt IE 8]>
<!-->
<html class="no-js" lang="en">
<!--<![endif]-->

<head>
    <meta charset="utf-8" />
    <!-- Set the viewport width to device width for mobile -->
    <meta name="viewport" content="width=device-width" />
    <title>
        PracticeUpdate : Expert Opinion Item
    </title>
    <link rel="stylesheet" href="assets/css/app.css">
    <link rel="stylesheet" href="assets/css/font-awesome.css">
    <link rel="stylesheet" href="assets/css/fc-webicons.css">
    <link rel="stylesheet" href="assets/css/foundation-icons-general.css">
    <script src="assets/js/foundation/modernizr.foundation.js">
    </script>
    <!-- IE Fix for HTML5 Tags -->
    <!--[if lt IE 9]>
        <script src="http://html5shiv.googlecode.com/svn/trunk/html5.js">
        </script>
    <![endif]-->
</head>

<body id="page" class="update off-canvas slide-nav expert-opinion-item logged-out">
    <div class="widget ad">
        <div id="leaderboard" class="Breast ad-container">
            <div class="ad-title">
                <span class="ad-title-text">
                    advertisement
                </span>
            </div>
            <!--/.ad-title-->
            <div id="leaderboardcontent" class="ad-content">
            </div>
            <!--.ad-content-->
        </div>
        <!--/#leaderboard.ad-container-->
    </div>
    <!--/.widget.ad-->
    <div class="page-header">
    </div>
    <!--/.page-header-->
    <div class="page-content">
        <section role="main">
            <div class="single-item-container">
                <article class="type-expert-opinion single-item">
                    <!-- info taken from: http://oncologystat.com/viewpoints/seminal_articles/Seminal_Articles_Germ_Cell_Tumors.html
                    -->
                    <div class="item-header-container">
                        <header class="item-header">
                            <div class="flag-container">
                                <span class="flag featured">
                                    <i class="icon-bolt">
                                    </i>
                                    featured
                                </span>
                                <span class="flag story-of-the-week">
                                    <i class="icon-bolt">
                                    </i>
                                    story of the week
                                </span>
                            </div>
                            <div class="meta pub-meta">
                                <span class="item-type">
                                    Seminal Article
                                </span>
                                <span class="item-pub-date">
                                    <time datetime="12-12-19">
                                        December 19, 2012
                                </span>
                            </div>
                            <hgroup class="item-title-container">
                                <h1 class="item-title">
                                    Seminal Articlesâ€”Lung Cancer
                                </h1>
                                <p class="item-citation">
                                    <!-- {{source.citation}} -->
                                    2012 Mar 6, Jean-Yves Douillard, MD, PhD, Editor: Patrick Morris, MD
                                </p>
                            </hgroup>
                            <!-- /.item-title-container -->
                        </header>
                    </div>
                    <!--/.item-header-container-->
                    <div class="item-content-container">
                        <div class="item-content">
                            <div class="item-content-section">
                                <section class="seminal-article-body">
                                    <div class="seminal-article-body-container">
                                        <div class="source-container">
                                            <div class="vcard">
                                            </div>
                                            <!--/.vcard-->
                                        </div>
                                        <!--/.source-container-->
                                        <p>Based on our expert's review, here are the must-read articles for every oncologist
										  about lung cancer.</p><strong>Non&ndash;Small-Cell Lung Cancer</strong>

											  <p><strong>Screening</strong></p>

										  <p>1. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose
										  computed tomographic screening. <a target="_blank" href=
										  "http://www.nejm.org/doi/full/10.1056/NEJMoa1102873">N Engl J Med.
										  2011;365(5):395-409</a>. <strong>Free</strong></p>

											  <p><strong>Staging</strong></p>

										  <p>2. Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with
										  combined PET&ndash;CT. <a target="_blank" href=
										  "http://www.nejm.org/doi/full/10.1056/NEJMoa0900043">N Engl J Med. 2009;361:32-39</a>.
										  <strong>Free</strong></p>

										  <p>Surgery for NSCLC</p>

										  <p>3. Albain KS, RS Swann, VW Rusch, et al. Radiotherapy plus chemotherapy with or
										  without surgical resection for stage III non-small-cell lung cancer: a phase III
										  randomised controlled trial. <a target="_blank" href=
										  "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60737-6/abstract">Lancet.
										  2009;374:379-386</a>.</p>


											  <p><strong>Adjuvant Therapy</strong></p>

										  <p>4. Arriagada R, Bergman B, Dunant A, et al. The international adjuvant lung cancer
										  trial collaborative group. Cisplatin-based adjuvant chemotherapy in patients with
										  completely resected non&ndash;small-cell lung cancer. <a target="_blank" href=
										  "http://www.nejm.org/doi/pdf/10.1056/NEJMoa031644">N Engl J Med.
										  2004;350(4):351-360</a>. <strong>Free</strong></p>

										  <p>5. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs.
										  observation in resected non&ndash;small-cell lung cancer. <a target="_blank" href=
										  "http://www.nejm.org/doi/full/10.1056/NEJMoa043623">N Engl J Med.
										  2005;352:2589-2597</a>. <strong>Free</strong></p>

										  <p>6. Olaussen KA, Dunant A, Fouret P, et al. DNA repair by ERCC1 in
										  non&ndash;small-cell lung cancer and cisplatin-based adjuvant chemotherapy. <a target=
										  "_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa060570">N Engl J Med.
										  2006;355:983-991</a>. <strong>Free</strong></p>

										  <p>7. Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin
										  versus observation in patients with completely resected stage IB&ndash;IIIA
										  non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association
										  [ANITA]): a randomised controlled trial. <a target="_blank" href=
										  "http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2806%2970804-X/fulltext">
										  Lancet Oncol. 2006;7:719-727</a>.</p>

										  <p>8. Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant paclitaxel plus carboplatin
										  compared with observation in stage IB non&ndash;small-cell lung cancer: CALGB 9633 With
										  the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central
										  Cancer Treatment Group Study Groups. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/26/31/5043.long">J Clin Oncol. 2008 Nov
										  1;26(31):5043-5051</a>. Free at <a target="_blank" href=
										  "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652093/?tool=pubmed">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652093/?tool=pubmed</a></p>

										  <p>9. Scagliotti GV, Pastorino U, Vansteenkiste JF, et al. Randomized Phase III Study
										  of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to
										  IIIA Non&ndash;Small-Cell Lung Cancer. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/30/2/172.abstract">J Clin Oncol. Jan 10,
										  2012:30;172-178</a>.</p>

										  <p>10. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung Adjuvant Cisplatin Evaluation:
										  A Pooled Analysis by the LACE Collaborative Group. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/26/21/3552.long">J Clin Oncol. 2008 Jul
										  20;26(21):3552-3559</a>.</p>
											  <p><strong>Chemotherapy for Metastatic Disease</strong></p>

										  <p>11. Kelly K, Crowley J, Bunn PA Jr, et al. Randomized phase III trial of paclitaxel
										  plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with
										  advanced non&ndash;small-cell lung cancer: a Southwest Oncology Group Trial. <a target=
										  "_blank" href="http://jco.ascopubs.org/content/19/13/3210.full">J Clin Oncol.
										  2001;19(13):3210-3218</a>.</p>

										  <p>12. Herbst RS, Khuri FR, Lu C, et al. The novel and effective nonplatinum, nontaxane
										  combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma:
										  potential for decreased toxicity and combination with biological therapy. <a target=
										  "_blank" href="http://onlinelibrary.wiley.com/doi/10.1002/cncr.10629/full">Cancer.
										  2002;95(2):340-353</a>. <strong>Free</strong></p>

										  <p>13. Danson S, Middleton, MR, O&acirc;&euro;&trade;Byrne KJ, et al. Phase III trial
										  of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or
										  mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung
										  carcinoma. <a target="_blank" href=
										  "http://onlinelibrary.wiley.com/doi/10.1002/cncr.11535/pdf">Cancer 2003;98:542-553</a>.
										  <strong>Free</strong></p>

										  <p>14. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy
										  regimens for advanced non&ndash;small-cell lung cancer. <a target="_blank" href=
										  "http://www.nejm.org/doi/full/10.1056/NEJMoa011954">N Engl J Med. 2002;346:92-98</a>.
										  <strong>Free</strong></p>

										  <p>15. Fossella F, Pereira JR, von Pawel J, et al. Randomized, multinational, phase III
										  study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for
										  advanced non&ndash;small-cell lung cancer: the TAX 326 study group. <a target="_blank"
										  href="http://jco.ascopubs.org/content/21/16/3016.full.pdf">J Clin Oncol. 2003 Aug
										  15;21(16):3016-3024. Epub 2003 Jul 1</a>.</p>

										  <p>16. Hanna N, Shepherd F, Fossella FV, et al. Randomized phase III trial of
										  pemetrexed versus docetaxel in patients with non&ndash;small-cell lung cancer
										  previously treated with chemotherapy. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/22/9/1589.full.pdf+html">J Clin Oncol.
										  2004;22(9):1589-1597</a>.</p>

										  <p>17. Sandler A, Gray R, Perry MC, et al. Paclitaxel&ndash;carboplatin alone or with
										  bevacizumab for non&ndash;small-cell lung cancer. <a target="_blank" href=
										  "http://www.nejm.org/doi/full/10.1056/NEJMoa061884">N Engl J Med.
										  2006;355:2542-2550</a>. <strong>Free</strong></p>

										  <p>18. NSCLC Meta-Analyses Collaborative Group. Chemotherapy in addition to supportive
										  care improves survival in advanced non&ndash;small-cell lung cancer: a systematic
										  review and meta-analysis of individual patient data from 16 randomized controlled
										  trials. <a target="_blank" href="http://jco.ascopubs.org/content/26/28/4617.full">J
										  Clin Oncol. 2008;17:7162</a>. <strong>Free at</strong><a target="_blank" href=
										  "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653127/?tool=pubmed">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653127/?tool=pubmed</a>.</p>

										  <p>19. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin
										  plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with
										  advanced-stage non&ndash;small-cell lung cancer. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/26/21/3543.full">J Clin Oncol.
										  2008;26(21):3543-3551</a>.</p>

										  <p>20. Pirker R, Pereira JR, Szczesna A, et al. Cetuximab plus chemotherapy in patients
										  with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III
										  trial. <a target="_blank" href=
										  "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2809%2960569-9/fulltext#article_upsell">
										  Lancet. 2009;373:1525-1531</a>.</p>

										  <p>21. Ciuleanu T, Brodowicz T, Zielinski C, et al. Maintenance pemetrexed plus best
										  supportive care versus placebo plus best supportive care for non-small-cell lung
										  cancer: a randomised, double-blind, phase 3 study. <a target="_blank" href=
										  "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2809%2961497-5/abstract">
										  Lancet. 2009;374(9699):1432-1440</a>.</p>

										  <p>22. Azzoli CG, Temin S, Aliff T, et al. 2011 Focused Update of 2009 American Society
										  of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV
										  Non&ndash;Small-Cell Lung Cancer. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/early/2011/09/06/JCO.2010.34.2774.full.pdf">J Clin
										  Oncol. 2011;29:1-8</a>.</p>

										  <p>23. Temel JS, Greer JA, Muzikansky A, et al. Early Palliative Care for Patients with
										  Metastatic Non&ndash;Small-Cell Lung Cancer. <a target="_blank" href=
										  "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1000678">N Engl J Med. 2010 Aug
										  19;363(8):733-42</a>. <strong>Free</strong></p>
											  <p><strong>Chemo-RT</strong></p>
										  <p>24. Albain KS, Crowley JJ, Turrisi AT III, et al. Concurrent cisplatin, etoposide,
										  and chest radiotherapy in pathologic stage IIIB non&ndash;small-cell lung cancer: A
										  Southwest Oncology Group Phase II Study, SWOG 9019. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/20/16/3454.long">J Clin Oncol.
										  2002;20(16):3454-3460</a>.</p>

										  <p>25. Belani CP, Choy H, Bonomi P, et al. Combined chemoradiotherapy regimens of
										  paclitaxel and carboplatin for locally advanced non&ndash;small-cell lung cancer: a
										  randomized phase II locally advanced multi-modality protocol. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/23/25/5883.full">J Clin Oncol. 2005;55:405</a>.</p>
											  <p><strong>Epidermal Growth Factor Receptor</strong></p>

										  <p>26. Shepherd FA, Pereira JR, Ciuleanu T, et al. Erlotinib in previously treated
										  non&ndash;small-cell lung cancer. <a target="_blank" href=
										  "http://www.nejm.org/doi/pdf/10.1056/NEJMoa050753">N Engl J Med. 2005;353:123-132</a>.
										  <strong>Free</strong></p>

										  <p>27. Tsao M-S, Sakurada A, Cutz J-C, et al. Erlotinib in lung cancer&mdash;&mdash;
										  molecular and clinical predictors of outcome. <a target="_blank" href=
										  "http://www.nejm.org/doi/full/10.1056/NEJMoa050736">N Engl J Med. 2005;353:133-144</a>.
										  <strong>Free</strong></p>

										  <p>28. Mok TS, Wu Y-L, Thongprasert S, et al. Gefitinib or carboplatin&ndash;paclitaxel
										  in pulmonary adenocarcinoma. <a target="_blank" href=
										  "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0810699">N Engl J Med. 2009;361:947-957</a>.
										  <strong>Free</strong></p>

										  <p>29. Inoue A, Kobayashi K, Usui K, et al. First-line gefitinib for patients with
										  advanced non&ndash;small-cell lung cancer harboring epidermal growth factor receptor
										  mutations without indication for chemotherapy. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/27/9/1394.full.pdf">J Clin Oncol.
										  2009;27(9):1394-1401</a>.</p>

										  <p>30. Zhou C, Wu Y-L, Chen G, et al. Erlotinib versus chemotherapy as first-line
										  treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer
										  (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. <a target=
										  "_blank" href=
										  "http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2811%2970184-X/abstract.">
										  Lancet Oncol. 2011;12(8):735-742</a>. Elsevier</p>

										  <p>31. Rosell R, Gervais R, Vergnenegre A, et al. Erlotinib versus chemotherapy (CT) in
										  advanced non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor
										  receptor (EGFR) mutations: Interim results of the European Erlotinib Versus
										  Chemotherapy (EURTAC) phase III randomized trial. <a target="_blank" href=
										  "http://www.asco.org/ascov2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=102&amp;abstractID=78285">
										  J Clin Oncol 29: 2011 (suppl; abstr 7503)</a>.</p>
											  <p><strong>ALK Inhibitors</strong></p>

										  <p>32. Kwak EL, Bang Y-J, Camidge R, et al. Anaplastic lymphoma kinase inhibition in
										  non&ndash;small-cell lung cancer. <a target="_blank" href=
										  "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1006448">N Engl J Med.
										  2010;363:1693-1703</a>. <strong>Free</strong></p>

										  <p><strong>Small Cell Lung Cancer</strong></p>

											  <p><strong>Chemotherapy</strong></p>

										  <p>33. Sundstr&Atilde;&cedil;m S, Bremnes RM, Kaasa S, et al. Cisplatin and etoposide
										  regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in
										  small-cell lung cancer: Results from a randomized phase III trial with 5 years'
										  follow-up. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/20/24/4665.full.pdf">J Clin Oncol. 2002 Dec
										  15;20(24):4665-4672</a>.</p>

										  <p>34. Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with
										  etoposide plus cisplatin for extensive small-cell lung cancer. <a target="_blank" href=
										  "http://www.nejm.org/doi/full/10.1056/NEJMoa003034">N Engl J Med. 2002 Jan
										  10;346(2):85-91</a>. <strong>Free</strong></p>

										  <p>35. O'Brien MER, Ciuleanu T-E, Tsekov H, et al. Phase III trial comparing supportive
										  care alone with supportive care with oral topotecan in patients with relapsed
										  small-cell lung cancer. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/24/34/5441.full">J Clin Oncol. 2006 Dec
										  1;24(34):5441-5447</a>.</p>

											  <p><strong>Thoracic Radiation</strong></p>

										  <p>36. Turrisi AT, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic
										  radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and
										  etoposide. <a target="_blank" href=
										  "http://www.nejm.org/doi/pdf/10.1056/NEJM199901283400403">N Engl J Med. 1999 Jan
										  28;340(4):265-271</a>. <strong>Free</strong></p>

										  <p>37. Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus
										  sequential thoracic radiotherapy in combination with cisplatin and etoposide for
										  limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group
										  Study 9104. <a target="_blank" href=
										  "http://jco.ascopubs.org/content/20/14/3054.full.pdf">J Clin Oncol. 2002 Jul
										  15;20(14):3054-3060</a>.</p>

											  <p><strong>Cranial Radiation</strong></p>

										  <p>38. Aup&Atilde;&copy;rin A, Arriagada R, Pignon J-P, et al. Prophylactic cranial
										  irradiation for patients with small-cell lung cancer in complete remission.
										  Prophylactic Cranial Irradiation Overview Collaborative Group. <a target="_blank" href=
										  "http://www.nejm.org/doi/pdf/10.1056/NEJM199908123410703">N Engl J Med.
										  1999;341:476-484</a>. <strong>Free</strong></p>

										  <p>39. Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in
										  extensive small-cell lung cancer. <a target="_blank" href=
										  "http://www.nejm.org/doi/pdf/10.1056/NEJMoa071780">N Engl J Med. 2007 Aug
										  16;357(7):664-672</a>. <strong>Free</strong></p>
                                    </div>
                                    <!--/.seminal-article-body-container -->
                                </section>
                                <!-- /.seminal-article-body -->
                            </div>
                            <!-- ./item-content-section -->
                        </div>
                        <!-- ./item-content -->
                    </div>
                    <!-- /.item-conten-container -->
                    <hr />
                    <footer class="copyright item-footer">
                        <img class="logo" src="content/img/feed/imng_logo.gif" alt="IMNG Medical Media"
                        />
                        <p>
                            Copyright &copy; 2012 Elsevier
                        </p>
                    </footer>
            </div>
            <!--/.item-container-->
            <div class="recommended">
                <div class="recent">
                </div>
                <!--/.recent-->
                <div class="ad">
                    <img src="http://placehold.it/300x250" align="ad" title="ad" />
                </div>
            </div>
            <!--/.recommended-->
        </section>
        <!--/[role="main"]-->
        <section id="sidebar" role="complementary">
            <div class="dashboard">
                <div class="panel cta register">
                    <p>
                        <!-- Meet Our Experts -->
                        Become a member to customize this page.
                        <p>
                            <a class="button" href="#action-register">Register for free</a>
                </div>
                <!--/.panel.cta.register-->
                <div class="component user-console">
                </div>
                <!--/.component.user-console-->
                <div class="component user-topic">
                </div>
                <!--/.component.user-topic-->
                <div class="component topic-spotlight">
                </div>
                <!--/.component.topic-spotlight-->
                <div class="panel">
                    <img src="http://placehold.it/200x200" />
                    <p>
                        <!-- Meet Our Experts -->
                        Meet our Advisory and Editorial Boards comprised of physician editors
                        and world-renowned experts.
                        <p>
                </div>
            </div>
            <!--/.sidebar-->
        </section>
        <!--/.[role="complimentary"]-->
    </div>
    <!--/.page-content-->
	<div class="page-footer-container">
    <footer class="page-footer">
    </footer>
	</div><!-- /.page-footer-container -->
    <!-- /.page-footer -->
    <!-- Included JS Files (Uncompressed) -->
    <script src="assets/js/foundation/jquery.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.accordion.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.alerts.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.buttons.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.forms.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.mediaQueryToggle.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.navigation.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.orbit.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.reveal.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tabs.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tooltips.js">
    </script>
    <script src="assets/js/foundation/jquery.placeholder.js">
    </script>
    <script src="assets/js/foundation/app.js">
    </script>
    <script src="assets/js/foundation/jquery.offcanvas.js">
    </script>
    <script src="assets/js/mustache.js">
    </script>
    <!-- Mustache - homepage feed template -->
    <script>
                    	<!--
	Mustache - homepage feed template -->
	$.getJSON('content/json/feed.json', function(data) {
	    $.get('assets/mustache/feed-item.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.stream-container').html(html);
	    });

	});

	<!--
	Mustache - homepage recent template -->
	$.getJSON('content/json/recent.json', function(data) {
	    $.get('assets/mustache/recent.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.recent').html(html);
	    });

	});

	<!--
	Mustache - homepage user - console template -->
	$.getJSON('content/json/user-console.json', function(data) {
	    $.get('assets/mustache/user-console.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-console').html(html);
	    });
	});

	<!--
	Mustache - homepage user - topic template -->
	$.getJSON('content/json/user-topic.json', function(data) {
	    $.get('assets/mustache/user-topic.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-topic').html(html);
	    });
	});

	<!--
	Mustache - homepage topic - spotlight template -->
	$.getJSON('content/json/topic-spotlight.json', function(data) {
	    $.get('assets/mustache/topic-spotlight.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.topic-spotlight').html(html);
	    });
	});
</script>
</body>

</html>